207 related articles for article (PubMed ID: 24720377)
1. Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.
Nilsen A; Miley GP; Forquer IP; Mather MW; Katneni K; Li Y; Pou S; Pershing AM; Stickles AM; Ryan E; Kelly JX; Doggett JS; White KL; Hinrichs DJ; Winter RW; Charman SA; Zakharov LN; Bathurst I; Burrows JN; Vaidya AB; Riscoe MK
J Med Chem; 2014 May; 57(9):3818-34. PubMed ID: 24720377
[TBL] [Abstract][Full Text] [Related]
2. Role of Trifluoromethyl Substitution in Design of Antimalarial Quinolones: a Comprehensive Review.
Romero AH
Top Curr Chem (Cham); 2019 Mar; 377(2):9. PubMed ID: 30835005
[TBL] [Abstract][Full Text] [Related]
3. Optimization of endochin-like quinolones for antimalarial activity.
Winter R; Kelly JX; Smilkstein MJ; Hinrichs D; Koop DR; Riscoe MK
Exp Parasitol; 2011 Feb; 127(2):545-51. PubMed ID: 21040724
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial quinolones: synthesis, potency, and mechanistic studies.
Winter RW; Kelly JX; Smilkstein MJ; Dodean R; Hinrichs D; Riscoe MK
Exp Parasitol; 2008 Apr; 118(4):487-97. PubMed ID: 18082162
[TBL] [Abstract][Full Text] [Related]
5. Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity.
Cross RM; Monastyrskyi A; Mutka TS; Burrows JN; Kyle DE; Manetsch R
J Med Chem; 2010 Oct; 53(19):7076-94. PubMed ID: 20828199
[TBL] [Abstract][Full Text] [Related]
6. Quinolone-3-diarylethers: a new class of antimalarial drug.
Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
[TBL] [Abstract][Full Text] [Related]
7. Novel Endochin-Like Quinolones Exhibit Potent
van Schalkwyk DA; Riscoe MK; Pou S; Winter RW; Nilsen A; Duffey M; Moon RW; Sutherland CJ
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094134
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Deuterated Endochin-Like Quinolones.
Pou S; Winter RW; Liebman KM; Dodean RA; Nilsen A; DeBarber A; Doggett JS; Riscoe MK
J Labelled Comp Radiopharm; 2024 May; 67(5):186-196. PubMed ID: 38661253
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-phenoxyethoxy)-4(1H)-quinolones.
Cross RM; Namelikonda NK; Mutka TS; Luong L; Kyle DE; Manetsch R
J Med Chem; 2011 Dec; 54(24):8321-7. PubMed ID: 22111907
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity of some quinolone derivatives against Plasmodium falciparum in vitro.
Domínguez J; Basante W; Charris J; Riggione F
Farmaco; 1996 Jun; 51(6):407-12. PubMed ID: 8766223
[TBL] [Abstract][Full Text] [Related]
11. Progress in the Optimization of 4(1
Brockmeyer F; Manetsch R
Chimia (Aarau); 2017 Apr; 71(4):213-219. PubMed ID: 28446339
[TBL] [Abstract][Full Text] [Related]
12. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
[TBL] [Abstract][Full Text] [Related]
13. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity.
Domínguez JN; Charris JE; Lobo G; Gamboa de Domínguez N; Moreno MM; Riggione F; Sanchez E; Olson J; Rosenthal PJ
Eur J Med Chem; 2001 Jun; 36(6):555-60. PubMed ID: 11525846
[TBL] [Abstract][Full Text] [Related]
15. Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Leung SC; Gibbons P; Amewu R; Nixon GL; Pidathala C; Hong WD; Pacorel B; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
J Med Chem; 2012 Mar; 55(5):1844-57. PubMed ID: 22364417
[TBL] [Abstract][Full Text] [Related]
16. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
[TBL] [Abstract][Full Text] [Related]
17. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
18. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
19. Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria.
Frueh L; Li Y; Mather MW; Li Q; Pou S; Nilsen A; Winter RW; Forquer IP; Pershing AM; Xie LH; Smilkstein MJ; Caridha D; Koop DR; Campbell RF; Sciotti RJ; Kreishman-Deitrick M; Kelly JX; Vesely B; Vaidya AB; Riscoe MK
ACS Infect Dis; 2017 Oct; 3(10):728-735. PubMed ID: 28927276
[TBL] [Abstract][Full Text] [Related]
20. Adenine Modification at C7 as a Viable Strategy to Potentiate the Antimalarial Activity of Quinolones.
Kurian J; Kumari V; Chaluvalappil SV; Anas M; Manhas A; Kalluruttimmal R; Kumar N; Manheri MK
ChemMedChem; 2022 Jan; 17(2):e202100472. PubMed ID: 34717044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
